ISN Representatives
Over 75 virtual volunteers operate the nonprofit International Scleroderma Network (ISN)!
ISN Representatives (Main Page) How to Volunteer
Dr. Alexandra Balbir-Gurman
ISN Russian Translator and ISN Russian Medical Editor
English Russian

Pansies by Shelley Ensz My name is Dr. Alexandra Balbir-Gurman. I am the ISN Russian Translator and ISN Russian Medical Editor. I am Senior Rheumatologist at Rambam Medical Center in Haifa, Israel.

I graduated from Chernovits School of Medicine in former USSR (Ukrain). I specialized in Internal Medicine and Rheumatology in Israel. In my work I am treating various rheumatological conditions, but my special interest is scleroderma. In our department of rheumatology together with pulmonary disease unit we are running a special clinic for lung manifestations of systemic diseases (including collagen vascular diseases).

In year 2000 I had the privilege to stay in Royal Free Hospital in London for six months training in research and clinical work under the supervision of Prof. Carol Black.

During the years that I have been involved in taking care of scleroderma patients, I became aware of the physical difficulties and psychological burden these patients have to cope with. Therefore, I am happy to participate in the international effort to provide information and support to scleroderma patients, including Russian patients.

Email Dr. Alexandra Balbir-Gurman

Related Links
Long-Term Warfarin Treatment for Severe Raynaud's Phenomenon and Ischemic Skin Ulcers: An Open Study. This open study suggests that Wf is safe and potentially beneficial in patients with severe RP and ISU due to coagulation abnormalities or secondary to SSc. A. Balbir-Gurman. FRI0153 EULAR 2005. (Also see: Raynaud's Treatments and Digital Ulcers)
The effect of Ilomedin (IL) on Antioxidants Status in Patients with Raynaud's Phenomenon (RP) Secondary to Scleroderma Related Diseases (SRD). These findings indicate that IL, in addition to its vasodilator properties, has a favorable effect on the antioxidant system. The question, whether this effect is primary or secondary, has not been addressed in this study. A. Balbir-Gurman. FRI0088 EULAR 2003 (Also see: Raynaud's Treatments and Medications)
Keep on Surfing!
Go to Barg, Gary
Contact ISN. We are a full-service nonprofit agency.
Email: isn@sclero.org or
or post a message in our Sclero Forums !
Shop, Join or Donate Now
(Also see: Contact ISN )
International Scleroderma Network (ISN)
7455 France Ave So #266
Edina, MN 55435-4702
USA
Toll Free Hotline in U.S. 1-800-564-7099
Direct Line 952-831-3091 (U.S.)
(We are also known as the Scleroderma from A to Z web site.)
© Copyright 1998-2008 International Scleroderma Network
All Rights Reserved